1 Guidance

1 Guidance

1.1 There is sufficient evidence of efficacy of electrochemotherapy for treating metastases in the skin from tumours of non-skin origin and melanoma to support its use as a palliative treatment. There are no major safety concerns. Therefore, in the context of palliative treatment the procedure can be used with normal arrangements for clinical governance, consent and audit.

1.2 Patient selection should be carried out by an appropriate specialist multidisciplinary team.

1.3 This procedure should only be carried out by a clinician with specific training in the technique.

1.4 Clinicians should submit data on all patients undergoing electrochemotherapy (including details of case selection, methods of follow-up and outcomes) to the InspECT register, an international register dedicated to electrochemotherapy, and review clinical outcomes locally.

  • National Institute for Health and Care Excellence (NICE)